D2C haircare startup Xtovia has raised Rs 6.9 crore (approximately $730,000) in a pre-seed funding round led by V3 Ventures, as publicly reported on June 17, 2026. Consumer Collective by Atrium and a group of angel investors also participated in the round. Founded in 2025 and headquartered across Hyderabad and Bengaluru, the company is building a science-led haircare brand anchored in proprietary technology and clinical research.
Quick Highlights
- Founders: Navneet Misra and Dr. Tunga Madhu Babu
- Lead Investor: V3 Ventures
- Participating Investors: Consumer Collective by Atrium, angel investors
- Investor Background: V3 Ventures is co-founded by Arjun Vaidya, known for building Dr. Vaidya’s, a prominent Ayurvedic consumer brand
- Headquarters: Hyderabad / Bengaluru, India
- Announcement Date: June 17, 2026
Funding Breakdown
Use of Funds
Xtovia plans to deploy the pre-seed capital across four key areas: strengthening its intellectual property portfolio, building out its core team, supporting the brand’s market launch, and funding early-stage growth initiatives. The focus on IP development signals the company’s intent to deepen the defensibility of its proprietary TriLayerX Hair Tech platform, which is backed by more than 35 clinical studies.
Funding Timeline
This pre-seed round is Xtovia’s first disclosed external funding since its founding in 2025. No prior institutional rounds have been publicly reported.
Expansion Plans
Xtovia aims to broaden its digital retail footprint by expanding into additional online marketplaces and distribution channels beyond its initial launch points. Looking further ahead, the brand has set its sights on international markets, with a stated ambition to position itself as a global Indian beauty brand built for export. On the talent front, the company will use a portion of the funding specifically to build its core team.
Significance
Pre-seed rounds in the haircare segment rarely attract dedicated consumer venture capital backing at this stage, making V3 Ventures’ lead participation a notable signal of confidence in science-differentiated beauty brands. Xtovia’s emphasis on proprietary technology — specifically its TriLayerX Hair Tech supported by 35-plus clinical studies — positions it as a research-driven challenger in a D2C beauty market that is increasingly rewarding clinical credibility over marketing spend. For V3 Ventures, the investment continues a clear thesis around founder-led, ingredient-first consumer brands. If Xtovia executes on its IP-first roadmap, it could carve a defensible niche in both the domestic premium haircare segment and the growing global appetite for Indian beauty exports.
These details have been verified against multiple publicly available reports as of June 17, 2026.
For more coverage of deals like this, follow startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
